ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy (Q46229669)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 November 2008

edit

Language	Label	Description	Also known as
English	ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy	scientific article published on 20 November 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

title

ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

main subject

diarrhea

0 references

chemotherapy

1 reference

based on heuristic

inferred from title

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

rituximab

1 reference

based on heuristic

inferred from title

author

Sang-Hyun Hwang

object named as

Sang-Hyun Hwang

series ordinal

7

0 references

Hyeon Seok Eom

series ordinal

4

object named as

Hyeon-Seok Eom

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

author name string

In-Suk Kim

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

Hoon-Gu Kim

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

Dong Chul Kim

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

Sun-Young Kong

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

Ho-Jin Shin

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

Eun-Yup Lee

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

Gyeong-Won Lee

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

publication date

20 November 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

published in

Cancer Science

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

volume

99

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

page(s)

2496-2501

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

cites work

Single-nucleotide polymorphism (SNP) analysis in the ABC half-transporter ABCG2 (MXR/BCRP/ABCP1).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00985.X

retrieved

21 January 2018

Identifiers

DOI

10.1111/J.1349-7006.2008.00985.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

PubMed publication ID

19032367

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19032367

retrieved

20 December 2017

reference URL

http://europepmc.org/abstract/MED/19032367

ResearchGate publication ID

23496244

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46229669&oldid=2100534948"